GRFSNasdaqPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GIKLY
Grifols SA
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 17, 2026
$7.64+0.00 (0.00%)
Close on Oct 19, 2026
Share price
−$2.01 (−20.83%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Ex-dividend
Grifols SA grew revenue 9.4% to €7.21B over fiscal 2024. Operating income rose 52.4% to €1.19B, moving the operating margin from 11.9% to 16.5%. Free cash flow was €669.63M.
Revenue
€7.21B
+9.4% vs. a year earlier
Operating income
€1.19B
+52.4% vs. a year earlier
Free cash flow
€669.63M
FY2024
EPS, diluted
0.23 EUR
+283.3% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Dec 31, 2024
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- €7.21B
- Net income
- €156.92M
- EPS, diluted
- 0.23 EUR
- Free cash flow
- €669.63M
Valuation needs the share price. It fills in once daily prices are connected and converted from EUR.
Eleven years at a glance
Fiscal years 2014 to 2024, EUR
Revenue
€7.21B+9.4% YoY
Gross profit
€2.79B+12.5% YoY
Operating income
€1.19B+52.4% YoY
Net income
€156.92M+270.8% YoY
EPS, diluted
0.23 EUR+283.3% YoY
Free cash flow
€669.63M
Reported period